top of page
Pixen is here for you
to open a new Path to early-stage commercialization for BioPharma
by experts that have worked on every stage gate of the commercialisation process and know where the gaps are
Pixen software provides a first-in-class, end-to-end solution that seamlessly integrates R&D with commercialization expertise to help extract the highest value for the assets
PROBLEM:
Sub optimal use of funds for early-stage development and lack of integration of commercialization know how in BioPharma
Lack of quality strategic discussion and alignment
Not sufficient resources / infrastructure to help with the workload
No tools / structured processes for outside in
Opinions matter more in the absence of facts
Market speed faster than company
Intense competition, agile marketplace
PIXEN ADDRESSES MOST OF THE CRITICAL CHALLENGES THAT GETS IN THE WAY TO SUCCESS THROUGHOUT THE DEVELOPMENT PROCESS
LEADERSHIP & GOVERNANCE
-
R&D heavy management, leadership strength in science
-
Limited bandwidth for governance
OPERATIONAL & EXECUTION
-
Limited Clinical Development Expertise
-
Manufacturing & CMC Issues
-
Regulatory & Compliance Shortfalls
STRATEGIC ALIGNMENT
-
Inadequate Target Validation & Product Profiles
-
Misalignment of R&D and Commercial Strategy
-
Portfolio Management Challenges
ORGANIZATIONAL CULTURE & TALENT
-
Talent Acquisition & Retention
-
Cultural Resistance to Change or Collaboration
FINANCIAL & RESOURCE CONSTRAINTS
-
Capital Management
-
Resource Allocation
Integrating AI-driven analytics
and machine learning at every stage
from defining endpoints to forecasting commercial success
Problem:
Misaligned target profile
Pixen:
AI-powered Target Profile Builder with scenario simulation
Streamlined, Connected
Anchored on a Target
Right assets get the attention
Market Driven Valuation
Investment Optimization
Single Source of Truth
Confidence in Early-stage commercialization
Best In Class Profile
Clinically Robust
Best in class label
Commercially
Viable
Continuosly adaptive
LCM in place, ongoing upkeep and iteration
Developing a strategic profile that captures the full market value mapped to R&D capability is critical to success
Target Profile is based on multiple scenarios where confidence levels are captured along with sources / facts / rational and keeps updated in line with market or data changes.
Capturing different scenarios prepares the teams for
multiple views of both the valuation and trial management.
Competitiveness have multiple layers and need to be captured against all different types of data and sources
Valuation needs to reflect commercial dynamics and closely tied to endpoints and competitiveness scoring with multiple simulations and investor reports
bottom of page